keyword
https://read.qxmd.com/read/38648062/universal-tobacco-screening-and-opt-out-treatment-referral-strategy-among-patients-diagnosed-with-cancer-by-race-and-ethnicity
#1
JOURNAL ARTICLE
Gleneara E Bates-Pappas, Elizabeth Schofield, Lou-Anne R Chichester, Chris Kotsen, Lisa Carter-Bawa, Graham W Warren, Jamie S Ostroff
No abstract text is available yet for this article.
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38648061/biomarker-vs-mri-enhanced-strategies-for-prostate-cancer-screening-the-sthlm3-mri-randomized-clinical-trial
#2
JOURNAL ARTICLE
Lars Björnebo, Andrea Discacciati, Ugo Falagario, Hari T Vigneswaran, Fredrik Jäderling, Henrik Grönberg, Martin Eklund, Tobias Nordström, Anna Lantz
IMPORTANCE: Prostate cancer guidelines often recommend obtaining magnetic resonance imaging (MRI) before a biopsy, yet MRI access is limited. To date, no randomized clinical trial has compared the use of novel biomarkers for risk estimation vs MRI-based diagnostic approaches for prostate cancer screening. OBJECTIVE: To evaluate biomarker-based risk estimation (Stockholm3 risk scores or prostate-specific antigen [PSA] levels) with systematic biopsies vs an MRI-enhanced strategy (PSA levels and MRI with systematic and targeted biopsy) for the detection of clinically significant prostate cancer in a screening setting...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38648057/durvalumab-after-chemoradiotherapy-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer
#3
JOURNAL ARTICLE
Meghan J Mooradian, Ling Cai, Alice Wang, Yao Qiao, Pratibha Chander, Ryan M Whitaker
IMPORTANCE: The PACIFIC trial established consolidation durvalumab as the standard of care following chemoradiotherapy (CRT) for patients with unresectable stage III non-small cell lung cancer (NSCLC). Understanding its benefit in routine US clinical practice is critical. OBJECTIVE: To report characteristics, treatment patterns, and outcomes of patients who did or did not receive durvalumab. DESIGN, SETTING, AND PARTICIPANTS: Two prespecified cohorts were curated in this retrospective cohort study (SPOTLIGHT)...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38648056/prevalence-of-homologous-recombination-deficiency-among-patients-with-germline-rad51c-d-breast-or-ovarian-cancer
#4
JOURNAL ARTICLE
Sara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, Marcel Romey, Àlex Teulé, Gemma Llort, Ana Herrero, Pilar Sánchez-Henarejos, Anna Vallmajó, Santiago González-Santiago, Isabel Chirivella, Juana Maria Cano, Begoña Graña, Sara Simonetti, Isabela Díaz de Corcuera, Teresa Ramon Y Cajal, Judit Sanz, Sara Serrano, Andrea Otero, Cristina Churruca, Ana Beatriz Sánchez-Heras, Sonia Servitja, Carmen Guillén-Ponce, Joan Brunet, Carsten Denkert, Violeta Serra, Judith Balmaña
IMPORTANCE: RAD51C and RAD51D are involved in DNA repair by homologous recombination. Germline pathogenic variants (PVs) in these genes are associated with an increased risk of ovarian and breast cancer. Understanding the homologous recombination deficiency (HRD) status of tumors from patients with germline PVs in RAD51C/D could guide therapeutic decision-making and improve survival. OBJECTIVE: To characterize the clinical and tumor characteristics of germline RAD51C/D PV carriers, including the evaluation of HRD status...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38648017/an-innovative-breast-cancer-detection-framework-using-multiscale-dilated-densenet-with-attention-mechanism
#5
JOURNAL ARTICLE
Subhashini Ramachandran, Rajasekar Velusamy, Namakkal Venkataraman Srinivasan Sree Rathna Lakshmi, Chakaravarthi Sivanandam
Cancer-related deadly diseases affect both developed and underdeveloped nations worldwide. Effective network learning is crucial to more reliably identify and categorize breast carcinoma in vast and unbalanced image datasets. The absence of early cancer symptoms makes the early identification process challenging. Therefore, from the perspectives of diagnosis, prevention, and therapy, cancer continues to be among the healthcare concerns that numerous researchers work to advance. It is highly essential to design an innovative breast cancer detection model by considering the complications presented in the classical techniques...
April 22, 2024: Network: Computation in Neural Systems
https://read.qxmd.com/read/38647959/co-ii-coordination-complex-fluorescence-performances-and-combined-with-taxotere-hydrogels-on-breast-cancer-treatment-and-clinical-care
#6
JOURNAL ARTICLE
Hao Liu, Chengyi Wu, Haiying Yu
In this study, a novel coordination polymer {Co2 (Oaobtc)(bpe)(H2 O)4 ]}n (1) was synthesized under hydrothermal conditions using a hybrid ligand synthesis method, where H4Oobtc represents 2,3,3'-tricarboxylate azobenzene, and bpe represents 1,2-bis(4-pyridyl)ethylene. The obtained CP1 was characterized by elemental analysis (EA), powder X-ray diffraction (PXRD), and thermal gravimetric analysis (TGA). Fluorescence testing confirmed the excellent photoluminescent performance of compound 1, indicating its potential as a cyan-emitting fluorescent material...
April 22, 2024: Journal of Fluorescence
https://read.qxmd.com/read/38647634/in-vivo-epid-based-daily-treatment-error-identification-for-volumetric-modulated-arc-therapy-in-head-and-neck-cancers-with-a-hierarchical-convolutional-neural-network-a-feasibility-study
#7
JOURNAL ARTICLE
Yiling Zeng, Heng Li, Yu Chang, Yang Han, Hongyuan Liu, Bo Pang, Jun Han, Bin Hu, Junping Cheng, Sheng Zhang, Kunyu Yang, Hong Quan, Zhiyong Yang
We proposed a deep learning approach to classify various error types in daily VMAT treatment of head and neck cancer patients based on EPID dosimetry, which could provide additional information to support clinical decisions for adaptive planning. 146 arcs from 42 head and neck patients were analyzed. Anatomical changes and setup errors were simulated in 17,820 EPID images of 99 arcs obtained from 30 patients using in-house software for model training, validation, and testing. Subsequently, 141 clinical EPID images from 47 arcs belonging to the remaining 12 patients were utilized for clinical testing...
April 22, 2024: Physical and engineering sciences in medicine
https://read.qxmd.com/read/38647430/identifying-and-assessing-putative-allosteric-sites-and-modulators-for-cxcr4-predicted-through-network-modeling-and-site-identification-by-ligand-competitive-saturation
#8
JOURNAL ARTICLE
Tugce Inan, Robin Flinko, George K Lewis, Alexander D MacKerell, Ozge Kurkcuoglu
The chemokine receptor CXCR4 is a critical target for the treatment of several cancer types and HIV-1 infections. While orthosteric and allosteric modulators have been developed targeting its extracellular or transmembrane regions, the intramembrane region of CXCR4 may also include allosteric binding sites suitable for the development of allosteric drugs. To investigate this, we apply the Gaussian Network Model (GNM) to the monomeric and dimeric forms of CXCR4 to identify residues essential for its local and global motions located in the hinge regions of the protein...
April 22, 2024: Journal of Physical Chemistry. B
https://read.qxmd.com/read/38647152/eravacycline-an-antibacterial-drug-repurposed-for-pancreatic-cancer-therapy-insights-from-a-molecular-based-deep-learning-model
#9
JOURNAL ARTICLE
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben-Shabat, Lior Rokach
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a serious threat to health, with limited effective therapeutic options, especially due to advanced stage at diagnosis and its inherent resistance to chemotherapy, making it one of the leading causes of cancer-related deaths worldwide. The lack of clear treatment directions underscores the urgent need for innovative approaches to address and manage this deadly condition. In this research, we repurpose drugs with potential anti-cancer activity using machine learning (ML)...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38646849/network-pharmacology-and-molecular-docking-based-strategy-for-predicting-anti-tumour-mechanism-of-linarin
#10
JOURNAL ARTICLE
Jun Wang, Jingjing Cheng
The aim was to explore the anti-tumour mechanism of linarin (LIN) based on network pharmacology and molecular docking. PharmMapper database and GeneCards database were used to screen anti-tumour related targets of LIN. Enrichment analysis of GO and KEGG was conducted to predict the key targets and pathways. At last, LIN was docked with the key targets. ESR1, ESR2, EGFR, AR, TGFBR2, F2, MAPK10, MAPK14, CDK2 and HSP90AA1 were identified as the key targets. The key pathways included pathways in cancer, prostate cancer, pancreatic cancer and breast cancer...
April 22, 2024: Natural Product Research
https://read.qxmd.com/read/38646808/luteolin-inhibits-lung-cancer-cell-migration-by-negatively-regulating-twist1-and-mmp2-through-upregulation-of-mir-106a-5p
#11
JOURNAL ARTICLE
Qiang Wang, Mengyuan Chen, Xiaofang Tang
BACKGROUND: Luteolin, a common dietary flavonoid found in plants, has been shown to have anti-cancer properties. However, its exact mechanisms of action in non-small cell lung cancer (NSCLC) are still not fully understood, particularly its role in regulating broader genomic networks and specific gene targets. In this study, we aimed to elucidate the role of microRNAs (miRNAs) in NSCLC treated with luteolin, using A549 cells as a model system. MATERIALS AND METHODS: miRNA profiling was conducted on luteolin-treated A549 cells using Exiqon microarrays, with validation of selected miRNAs by qRT-PCR...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/38646708/immune-related-adverse-effects-recognition-and-initiation-of-appropriate-treatment-in-cancer-patients-on-immunotherapy
#12
JOURNAL ARTICLE
Riley Mohr, Anna Howard, Melanie Townsend
PURPOSE: Delayed or improper identification of immune-related adverse events (IRAEs) during cancer treatment can impact time to receive proper treatment. This study describes rates of IRAE recognition and appropriate treatment in adult patients with cancer at a community teaching hospital. METHODS: This single-center, retrospective, cohort study evaluated rates of proper IRAE treatment in conjunction with National Comprehensive Cancer Network (NCCN) guidelines. Secondary outcomes included time from presentation to IRAE diagnosis and hospital readmissions/repeat emergency department (ED) visits following initial admission for IRAE...
April 22, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38646416/artificial-neural-network-assisted-prediction-of-radiobiological-indices-in-head-and-neck-cancer
#13
JOURNAL ARTICLE
Saad Bin Saeed Ahmed, Shahzaib Naeem, Agha Muhammad Hammad Khan, Bilal Mazhar Qureshi, Amjad Hussain, Bulent Aydogan, Wazir Muhammad
BACKGROUND AND PURPOSE: We proposed an artificial neural network model to predict radiobiological parameters for the head and neck squamous cell carcinoma patients treated with radiation therapy. The model uses the tumor specification, demographics, and radiation dose distribution to predict the tumor control probability and the normal tissue complications probability. These indices are crucial for the assessment and clinical management of cancer patients during treatment planning. METHODS: Two publicly available datasets of 31 and 215 head and neck squamous cell carcinoma patients treated with conformal radiation therapy were selected...
2024: Frontiers in artificial intelligence
https://read.qxmd.com/read/38645446/application-value-of-the-automated-machine-learning-model-based-on-modified-ct-index-combined-with-serological-indices-in-the-early-prediction-of-lung-cancer
#14
JOURNAL ARTICLE
Leyuan Meng, Ping Zhu, Kaijian Xia
BACKGROUND AND OBJECTIVE: Accurately predicting the extent of lung tumor infiltration is crucial for improving patient survival and cure rates. This study aims to evaluate the application value of an improved CT index combined with serum biomarkers, obtained through an artificial intelligence recognition system analyzing CT features of pulmonary nodules, in early prediction of lung cancer infiltration using machine learning models. PATIENTS AND METHODS: A retrospective analysis was conducted on clinical data of 803 patients hospitalized for lung cancer treatment from January 2020 to December 2023 at two hospitals: Hospital 1 (Affiliated Changshu Hospital of Soochow University) and Hospital 2 (Nantong Eighth People's Hospital)...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38645065/stepwise-stiffening-softening-of-and-cell-recovery-from-reversibly-formulated-hydrogel-double-networks
#15
Irina Kopyeva, Ethan C Goldner, Jack W Hoye, Shiyu Yang, Mary C Regier, Kaitlyn R Vera, Ross C Bretherton, Cole A DeForest
UNLABELLED: Biomechanical contributions of the ECM underpin cell growth and proliferation, differentiation, signal transduction, and other fate decisions. As such, biomaterials whose mechanics can be spatiotemporally altered - particularly in a reversible manner - are extremely valuable for studying these mechanobiological phenomena. Herein, we introduce a poly(ethylene glycol) (PEG)-based hydrogel model consisting of two interpenetrating step-growth networks that are independently formed via largely orthogonal bioorthogonal chemistries and sequentially degraded with distinct bacterial transpeptidases, affording reversibly tunable stiffness ranges that span healthy and diseased soft tissues (e...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645034/single-cell-analysis-of-treatment-resistant-prostate-cancer-implications-of-cell-state-changes-for-cell-surface-antigen-targeted-therapies
#16
Samir Zaidi, Jooyoung Park, Joseph M Chan, Martine P Roudier, Jimmy L Zhao, Anuradha Gopalan, Kristine M Wadosky, Radhika A Patel, Erolcan Sayar, Wouter R Karthaus, D Henry Kates, Ojasvi Chaudhary, Tianhao Xu, Ignas Masilionis, Linas Mazutis, Ronan Chaligné, Aleksandar Obradovic, Irina Linkov, Afsar Barlas, Achim Jungbluth, Natasha Rekhtman, Joachim Silber, Katia Manova-Todorova, Philip A Watson, Lawrence D True, Colm M Morrissey, Howard I Scher, Dana Rathkopf, Michael J Morris, David W Goodrich, Jungmin Choi, Peter S Nelson, Michael C Haffner, Charles L Sawyers
UNLABELLED: Targeting cell surface molecules using radioligand and antibody-based therapies has yielded considerable success across cancers. However, it remains unclear how the expression of putative lineage markers, particularly cell surface molecules, varies in the process of lineage plasticity, wherein tumor cells alter their identity and acquire new oncogenic properties. A notable example of lineage plasticity is the transformation of prostate adenocarcinoma (PRAD) to neuroendocrine prostate cancer (NEPC)--a growing resistance mechanism that results in the loss of responsiveness to androgen blockade and portends dismal patient survival...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38645031/phosphorylation-driven-epichaperome-assembly-a-critical-regulator-of-cellular-adaptability-and-proliferation
#17
Gabriela Chiosis, Seth McNutt, Tanaya Roychowdhury, Chiranjeevi Pasala, Hieu Nguyen, Daniel Thorton, Sahil Sharma, Luke Boticelli, Chander Digwal, Suhasini Joshi, Nan Yang, Palak Panchal, Souparna Chakrabarty, Sadik Bay, Vladimir Markov, Charlene Kwong, Jeanine Lisanti, Sun Young Chung, Stephen Ginsberg, Pengrong Yan, Elisa de Stanchina, Adriana Corben, Shanu Modi, Mary Alpaugh, Giorgio Colombo, Hediye Erdjument-Bromage, Thomas Neubert, Robert Chalkley, Peter Baker, Alma Burlingame, Anna Rodina, Feixia Chu
The intricate protein-chaperone network is vital for cellular function. Recent discoveries have unveiled the existence of specialized chaperone complexes called epichaperomes, protein assemblies orchestrating the reconfiguration of protein-protein interaction networks, enhancing cellular adaptability and proliferation. This study delves into the structural and regulatory aspects of epichaperomes, with a particular emphasis on the significance of post-translational modifications in shaping their formation and function...
April 3, 2024: Research Square
https://read.qxmd.com/read/38644998/fibroblast-stromal-support-model-for-predicting-human-papillomavirus-associated-cancer-drug-responses
#18
Claire D James, Rachel L Lewis, Alexis L Fakunmoju, Austin J Witt, Aya H Youssef, Xu Wang, Nabiha M Rais, Apurva Tadimari Prabhakar, Raymonde Otoa, Molly L Bristol
UNLABELLED: Currently, there are no specific antiviral therapeutic approaches targeting Human papillomaviruses (HPVs), which cause around 5% of all human cancers. Specific antiviral reagents are particularly needed for HPV-related oropharyngeal cancers (HPV + OPCs) whose incidence is increasing and for which there are no early diagnostic tools available. We and others have demonstrated that the estrogen receptor alpha (ERα) is overexpressed in HPV + OPCs, compared to HPV-negative cancers in this region, and that these elevated levels are associated with an improved disease outcome...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38644620/dgat2-plays-a-crucial-role-to-control-esrraprox1-transcriptional-network-to-maintain-hepatic-mitochondrial-sustainability
#19
JOURNAL ARTICLE
Yoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo Kim
BACKGROUND: Diacylglycerol O-acyltransferase 2 (DGAT2) synthesizes triacylglycerol (TG) from diacylglycerol; therefore, DGAT2 is considered as a therapeutic target for steatosis. However, the consequence of inhibiting DGAT2 is not fully investigated due to side effects including lethality and lipotoxicity. In this article, we observed the role of DGAT2 in hepatocarcinoma. METHODS: The role of DGAT2 is analyzed via loss-of-function assay. DGAT2 knockdown (KD) and inhibitor treatment on HepG2 cell line was analyzed...
April 22, 2024: Diabetes & Metabolism Journal
https://read.qxmd.com/read/38644155/effect-of-sex-on-the-oncological-outcomes-in-response-to-immunotherapy-and-antibody-drug-conjugates-in-patients-with-urothelial-and-kidney-cancer-a-systematic-review-and-a-network-meta-analysis
#20
REVIEW
Clara Cerrato, Fabio Crocerossa, Michele Marchioni, Gianluca Giannarini, Shilpa Gupta, Laurence Albiges, Oscar Brouwer, Maarten Albersen, Christian Fankhauser, Marc Oliver Grimm, Giorgio Gandaglia, Morgan Roupret, Maria Carmen Mir
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) treatment, amid acknowledged sex-based disparities in these cancers. We conducted a systematic review and network meta-analysis (NMA) to identify sex-specific differences in the efficacy of ICI/ADC monotherapy or combination therapies for RCC and TCC survival, in metastatic and adjuvant settings...
April 20, 2024: European Urology Oncology
keyword
keyword
14341
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.